Delivery Order SPE2DB22D1106-SPE2DB25FENM2

Award Date 5/14/25
Potential Completion Date 5/15/25
Potential Value $49K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a delivery order to Amerisourcebergen Drug Corp., the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The $14,918.85 firm-fixed-price order is for the supply of 4,564,885,604 units of the drug Lupron Depot 3.75 mg kits. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $4,926.04 to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the supply of LUPRON DEPOT 11.25 MG 3MO KITS, with a performance period ending on May 10, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,468.16 firm fixed-price delivery order is for the supply of 4,568,247,946 units of the drug Lupron Depot 3.75 mg kits. The contract has an ultimate completion date of May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,474.80 firm fixed-price delivery order is for the supply of 4,567,939,724 units of the medication LUPRON DEPOT 3.75 MG KITS. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a $14,303.90 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564309694 LUPRON DEPOT 11.25 MG 3MO KITS. This order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,046.04, is for the supply of Lupron Depot 11.25 mg 3-month kits. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $22,001.58 firm-fixed-price delivery order is for 4,565,965,620 units of Lupron Depot 3.75 mg kits, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to procure a comprehensive range of medical commodities...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $6,183.30 to provide LUPRON DEPOT 3.75 MG KITS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lupron Depot 3.75 mg kits, a specialty medication used in various medical treatments. The award value is $25,699.51 and has a period of performance ending on October 29, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a firm fixed price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a for-profit pharmaceutical distribution company. The delivery order, valued at $6,431.16, is for the supply of Lupron Depot 11.25 mg 3-month kits. The order is placed under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen, which has a potential value of $999,999,999.00 and a performance period...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FENM2
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order valued at $49,219.01 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,249,853 units of Lupron Depot 3.75 mg kits. This award does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is likely part of the company's broader role in supplying a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/13/25, 10:59 AM